Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids.

Auteurs

Agostini G, Leprovots M, Jeandriens J, Lefort A, Libert F, Sclafani F, Langer I, Hendlisz A, Garcia MI

  • Date de publication

    January 2025

  • Type

    Article

  • Review

    Front Cell Dev Biol

  • Researcher's name

    HENDLISZ ALAIN

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Oncologique, Oncologie digestive

  • PMID

    40772227

  • DOI

    10.3389/fcell.2025.1631116